Overview

Study of ARO-AAT in Normal Adult Volunteers

Status:
Completed

Trial end date:
2020-03-21

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single- and multiple-ascending doses of ARO-AAT in healthy adult volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Arrowhead Pharmaceuticals